Gold Leaf Awards

Gold_Leaf_Logo

Launched in 2001, the Gold Leaf awards are given annually to recognize both companies and individuals who have made significant contributions to the biotech industry in Canada. The Awards’ importance to the recipients and the industry more broadly has grown significantly over the years. The remarkable individuals and companies we recognize through the Gold Leaf Awards are great examples of the core strengths of Canada’s biotech ecosystem.

Importantly, Canada’s global biotech success is founded in its ability to advance scientific innovation by leveraging a diverse and vibrant ecosystem comprised of individuals, companies and institutions located in every province across the country. It is this strength that establishes Canada’s biotech industry as a leader in developing the solutions that will help address the global social and economic challenges emerging from population growth and a changing climate.

2017 Winners

Company of the Year: enGene Inc.
Emerging company of the Year (Health): Turnstone Biologics
Emerging company of the Year (Agriculture/ Industrial): CO2 Solutions Inc.
Industry Catalyst: Dr. Ilse Treurnicht
Ecosystem Builder: Bioenterprise Corporation

These remarkable individuals and companies serve to demonstrate the value of innovation, leadership and how biotechnology is delivering solutions to the many pressing environmental, health and economic challenges society is grappling with as a result of global population growth. The various clusters of excellence throughout Canada where biotechnology is thriving showcase the very best we have on offer. The biotech ecosystem is building globally competitive Canadian companies. Biotechnology is becoming more central to supporting the economic and environmental transformation of Canada’s traditional economic cornerstone and job intensive industries, namely: forestry; energy; mining; agriculture; aerospace; manufacturing and resource management. Biotechnology innovation will support these sectors as they transform and compete in the emerging global bio-economy.

Bioenterprise Turnstone
 From left to right
The Honourable Kelvin K. Ogilvie, Senator – Past Chair of the Health Research Caucus
The Honourable Judith Seidman, Senator – Incoming Senate Representative of the Health Research Caucus
Andrew Casey, President and CEO BIOTECanada  
Jennifer Kalanda, Marketing Manager Bioenterprise Corporation
Mr. John Oliver, Member of Parliament Oakville – Chair of the Health Research Caucus
Ms. Carol Hughes – Member of Parliament, Assistant Deputy Speaker NDP Representative of the Health Research Caucus
From left to right
Ms. Carol Hughes – Member of Parliament, Assistant Deputy Speaker NDP Representative of the Health Research Caucus
The Honourable Kelvin K. Ogilvie, Senator – Past Chair of the Health Research Caucus
The Honourable Judith Seidman, Senator – Incoming Senate Representative of the Health Research Caucus
Andrew Casey, President and CEO BIOTECanada
Dr. John Bell, Founder Turnstone Biologics
Dr. David Stojdl, Founder Turnstone Biologics
Mr. John Oliver, Member of Parliament Oakville – Chair of the Health Research Caucus